Latest from Genique and our partners.
What we and the companies we represent are announcing, straight from their LinkedIn pages.
Latest from Genique
LinkedIn · company/genique-lifesciences
Pinned · 12 Oct 2026
PMS2 has a pseudogene, PMS2CL, that is near-identical to the 3' end of the gene. Short reads from one can map to the other, so a variant…
Loads from linkedin.com, which sets its own cookies.
28 Oct 2026 A change in the BRCA2 gene is identified in a breast tumour. But does it tell us whether the change was inherited or developed in the… 21 Oct 2026 An estimated 237,231 women in India were diagnosed with breast cancer in 2024. Genomic testing can play different roles at different… 16 Oct 2026 Introducing The Molecular Classroom | An Initiative by Genique Lifesciences in Collaboration with HAEMATOLOGY SOLUTIONS LTD Genique… 15 Oct 2026 Longer FLT3-ITDs can be challenging to detect using standard short-read alignment methods, making accurate detection and sizing important…
All Genique posts
Our partners
The latest from our partners.
Element Biosciences
AVITI™ · VITARI™ View page-
Pinned · 8 Oct 2026 What are you missing when your biology is split across assays? A screen can tell you which perturbation matters. Tissue can show you where… -
19 Oct 2026 Today, we are thrilled to announce the first shipment of Cytos™, a first-of-its-kind multiomics workflow that captures guide RNA, cell… -
12 Oct 2026 Imaging-based pooled screens show you what a perturbation does to a cell's shape. What if the same screen could also tell you what's… -
22 Sept 2026 Choosing a sequencing chemistry isn't just a checkbox. It can shape everything downstream, from cost to data quality to how future-proof…
SOPHiA GENETICS
AI-driven · SOPHiA DDM™ View page-
Pinned · 12 Oct 2026 Not all genes are straightforward to analyse. For hereditary cancer testing, PMS2 presents a particular challenge because of its highly… -
27 Oct 2026 🎀 This Breast Cancer Awareness Month, we recognize the discoveries moving patient care forward. Can we predict how a tumor will evade… -
26 Oct 2026 Implementation is often the silent bottleneck of innovation. Once you're ready to bring a new platform in-house, the hurdles can start to… -
19 Oct 2026 💡 What are you missing when you look at oncology data one modality at a time? Drug development generates a high volume of data from many…
Atrandi Biosciences
Single-cell · SPC View page-
1 Oct 2026 Whole transcriptome, plus targeted genotype at the loci you choose, including ones that aren't transcribed. All from the same cell. That's… -
3 Sept 2026 Another webinar? Fair. But if you work on strain engineering, enzyme discovery, or microbial communities that are difficult to culture… -
26 Aug 2026 A plate lets you run many steps. A droplet lets you run many cells. For a long time, single-cell work meant deciding which one you needed… -
18 Aug 2026 Musculoskeletal cancers carry genetic markers that tell clinicians how serious a case is. What they can't yet tell us is why. As Adam…
Gene Solutions
triSure NIPT · SPOT-MAS View page-
15 Oct 2026 New peer-reviewed evidence published in The Journal of Liquid Biopsy validates the upgraded ctDNA workflow powering Gene Solutions’… -
27 Sept 2026 🎗️ A Clinical Oncologist’s Perspective on Multi-Cancer Early Detection | Part 2 Not All Multi-Cancer Early Detection Tests Are the Same… -
26 Aug 2026 SPOT-MAS CRC: A Simple Blood Test to Help More People Access Colorectal Cancer Screening Colorectal cancer is one of the world’s most… -
17 Aug 2026 Cancer is often silent in its early stages. Detection shouldn't be. Catching cancer early can make a critical difference in treatment…
Diatech Pharmacogenetics
Oncology · PGx View page-
Pinned · 16 Jun 2026 ❤️ Thank you to Cancer Institute (WIA) for the trust placed in our solutions. This represents an important first step in introducing our… -
12 Oct 2026 🧬 Scientific Research Updates Molecular classification is central to risk stratification in endometrial cancer (EC). In this study, 85… -
1 Oct 2026 October is Breast Cancer Awareness Month! #BreastCancer remains one of the most common cancers worldwide. In 2024, around 2.4 million new… -
10 Aug 2026 🧬 Scientific Research Updates Approximately 85% of non-small cell lung cancers (NSCLCs) are diagnosed at advanced stages, where treatment…
Paragon Genomics
Panels · CleanPlex® View page-
Pinned · 19 Aug 2026 Can amplicon sequencing deliver reliable exon-level CNV detection in BRCA1 and BRCA2?... -
18 Sept 2026 Ready to evaluate a simpler approach to pharmacogenomics NGS? Paragon Genomics is offering a free 8-reaction CleanPlex® Pharmacogenomics… -
26 Aug 2026 Looking to bring a targeted NGS product to market? Paragon Genomics works with biotechnology and diagnostics companies to develop OEM… -
11 Aug 2026 Your targets. Your panel. Your research. NGS panels shouldn’t force your research into a predefined box. With CleanPlex® Custom NGS…